In early 2021, the Centers for Medicare & Medicaid Services (CMS) selected ReVIDA to participate in a national study to measure the impact of ReVIDA’s evidence-based, multidisciplinary treatment model.

ReVIDA is one of only 54 providers selected nationwide, and the only provider selected in ReVIDA’s service area.

The four-year project aims to increase access to quality addiction treatment services while improving the physical and behavioral health outcomes for Medicare beneficiaries.

Link: Tennessee addiction treatment companies join CMS demonstration | Education |

Link: ReVIDA Recovery® Centers selected for national Medicare demonstration project